前收市價 | 3.2000 |
開市 | 2.2000 |
買盤 | 0.0000 |
賣出價 | 4.9000 |
拍板 | 17.50 |
到期日 | 2024-07-19 |
今日波幅 | 2.2000 - 3.2000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 32 |
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript April 23, 2024 Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.14. KNSA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
Kiniksa Pharmaceuticals (KNSA) delivered earnings and revenue surprises of -78.57% and 4.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Arcturus' (ARCT) steady progress with its product candidate, ARCT-032, for the treatment of cystic fibrosis is encouraging.